Memantine-based NMDA receptor antagonist could help treat autism

A study published in Nature Communications identified myocyte enhancer factor 2C (MEF2C) mutations as a source of abnormal brain development and function and suggests an NMDA receptor

Read the full 279 word article

User Sign In